United States · FDA National Drug Code directory
Triazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-451_fe714ed3-35c9-4c0c-b64c-d6e1ba0e685f
- Product NDC
- 43353-451
- Form
- TABLET
- Composition / generic term
- triazolam
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 19821115
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAZOLAM — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (43353-451-30) · 43353-451-30
- 60 TABLET in 1 BOTTLE (43353-451-53) · 43353-451-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →